Atrial Fibrillation

Uninterrupted Anticoagulation With Dabigatran Improves Atrial Fibrillation Ablation Outcomes, Expert Q&A

Uninterrupted Anticoagulation With Dabigatran Improves Atrial Fibrillation Ablation Outcomes, Expert Q&A

By

Incidence of major bleeding events was lower with dabigatran vs warfarin in atrial fibrillation ablation.

Atrial Fibrillation Associated With Higher Mortality in STEMI

Atrial Fibrillation Associated With Higher Mortality in STEMI

By

Atrial fibrillation was associated with a higher risk of adjusted in-hospital mortality and bleeding complications after both PCI and CABG.

Anticoagulation Therapy in Patients With Atrial Fibrillation

Anticoagulation Therapy in Patients With Atrial Fibrillation

According to research, many patients with afib who were later diagnosed with acute ischemic stroke may not have been receiving appropriate anticoagulation therapy.

Higher CHADS<sub>2</sub> Score in Atrial Fibrillation Linked to Increased Dementia Risk

Higher CHADS2 Score in Atrial Fibrillation Linked to Increased Dementia Risk

By

CHADS2 scores in patients with atrial fibrillation are associated with increased risk of developing dementia.

Prestroke CHA2DS2-VASc Predictive of Stroke Severity, Mortality

Prestroke CHA2DS2-VASc Predictive of Stroke Severity, Mortality

By

The relationship between prestroke CHA2DS2-VASc score and stroke severity and functional outcome in patients with AF and acute ischemic stroke was evaluated.

Atrial Fibrillation Recurrence Not Reduced With Aggressive Blood Pressure Control

Atrial Fibrillation Recurrence Not Reduced With Aggressive Blood Pressure Control

By

Aggressive blood pressure treatment did not reduce atrial fibrillation recurrence after catheter ablation.

Dabigatran Bleeding Risk Stratified by Age in Atrial Fibrillation

Dabigatran Bleeding Risk Stratified by Age in Atrial Fibrillation

By

Compared with warfarin, there were lower rates of stroke with dabigatran 110 mg and 150 mg twice daily.

Post-Operative Stroke Risk in Coronary Artery Bypass Graft

Post-Operative Stroke Risk in Coronary Artery Bypass Graft

A meta-analysis of various CABG techniques assessed each for stroke risk, bleeding complications, atrial fibrillation, and mortality.

Oral Anticoagulant Stroke Risk in Atrial Fibrllation

Oral Anticoagulant Stroke Risk in Atrial Fibrllation

By

Patients taking apixaban were more likely to experience ischemic stroke or systemic embolism vs patients taking warfarin.

Implantable Cardioverter-Defibrillators, Pacemakers Can Receive MRI

Implantable Cardioverter-Defibrillators, Pacemakers Can Receive MRI

None of the patients had device failure during the MRI; however, 6 patients did have atrial fibrillation or flutter but each case stopped on its own.

Heart Failure, Atrial Fibrillation: Possible Markers for Mild Alzheimer's

Heart Failure, Atrial Fibrillation: Possible Markers for Mild Alzheimer's

By

Patients with both heart failure and atrial fibrillation had a pattern of milder Alzheimer's pathology.

NOACS More Adopted Into Clinical Practice

NOACS More Adopted Into Clinical Practice

Of the 80% of patients prescribed oral anticoagulants, nearly 50% were prescribed non-vitamin K antagonist anticoagulants.

Atrial Fibrillation Hospitalization Rates

Atrial Fibrillation Hospitalization Rates

While hospitalization rates increased for patients with atrial fibrillation, mortality rates decreased.

Periprocedural Anticoagulation in Atrial Fibrillation: American College of Cardiology Decision Pathway

Periprocedural Anticoagulation in Atrial Fibrillation: American College of Cardiology Decision Pathway

By

The American College of Cardiology released a decision pathway for managing periprocedural anticoagulation in patients with nonvalvular atrial fibrillation

Can Stroke Predict Atrial Fibrillation?

Can Stroke Predict Atrial Fibrillation?

By

The researchers assessed 1809 patients with incidence of stroke and atrial fibrillation.

Atrial Fibrillation Catheter Ablation Successful, But With Complications

Atrial Fibrillation Catheter Ablation Successful, But With Complications

While catheter ablation for atrial fibrillation is generally successful, 46% of patients still had to take antiarrhythmic drugs 1 year later.

Insulin, Not Diabetes, May Increase Thromboembolic Risk in Atrial Fibrillation

Insulin, Not Diabetes, May Increase Thromboembolic Risk in Atrial Fibrillation

By

Insulin-requiring diabetes was associated with a higher risk for stroke/systemic embolism incidence at 1-year follow-up.

LAA Closure Device in Atrial Fibrillation Yields High Success, Low Complication Rates

LAA Closure Device in Atrial Fibrillation Yields High Success, Low Complication Rates

By

The left atrial appendage closure device was found to have excellent success and low complication rates in a post-FDA approval study.

Atrial Fibrillation Inpatient Costs: Dabigatran, Rivaroxaban, and Warfarin

Atrial Fibrillation Inpatient Costs: Dabigatran, Rivaroxaban, and Warfarin

Compared with warfarin, inpatient costs for newly diagnosed atrial fibrillation were lower for dabigatran and rivaroxaban.

Silent Cerebrovascular Disease Increases Risk for Future Stroke

Silent Cerebrovascular Disease Increases Risk for Future Stroke

By

Silent cerebrovascular disease appears to increase the risk for future symptomatic stroke.

Beta-Blockers for Heart Failure With Atrial Fibrillation

Beta-Blockers for Heart Failure With Atrial Fibrillation

Beta-blockers were associated with lower all-cause mortality in heart failure with reduced ejection fraction and atrial fibrillation, but not hospitalizations.

Oral Anticoagulant Therapy Use in Older Stroke Surivors

Oral Anticoagulant Therapy Use in Older Stroke Surivors

Almost half of the patients were not prescribed an oral anticoagulant despite a median CHA2DS2VASc score of 5.

Continuing Warfarin in Nonvalvular Atrial Fibrillation With Dementia

Continuing Warfarin in Nonvalvular Atrial Fibrillation With Dementia

Continuing wafarin after a diagnosis of dementia appears to have a protective effect in prevention of ischemic stroke, major bleeding, and all-cause mortality.

Understanding Obesity's Role in Atrial Fibrillation

Understanding Obesity's Role in Atrial Fibrillation

By

The comorbid conditions of obesity and atrial fibrillation require better prevention and treatment strategies.

Atrial Fibrillation Clinical Guidelines: A Review of the Evidence Base

Atrial Fibrillation Clinical Guidelines: A Review of the Evidence Base

By

While the number of recommendations has increased, level A evidence is assigned to only 8.8% of the atrial fibrillation clinical guidelines.

Recurrence of Atrial Fibrillation, Stroke After Ablation

Recurrence of Atrial Fibrillation, Stroke After Ablation

In patients with an event-free period of at least 12 months after atrial fibrillation ablation, risk of stroke or recurrent atrial fibrillation is low.

Off-Label Dosing of NOACs in Atrial Fibrillation Is a Concern

Off-Label Dosing of NOACs in Atrial Fibrillation Is a Concern

By

About 1 in 8 patients in the ORBIT-AF II registry were given "off-label" non-vitamin K antagonist doses.

Afib Catheter Ablation Associated with More Strokes in Elderly Patients

Afib Catheter Ablation Associated with More Strokes in Elderly Patients

Patients who are at least 75 years of age have a higher rate of strokes post-catheter ablation of atrial fibrillation compared with younger patients.

Atrial Fibrillation Risk Increased with Small Amounts of Alcohol

Atrial Fibrillation Risk Increased with Small Amounts of Alcohol

Risk of atrial fibrillation increased by 8% for each daily drink of alcohol.

Dangers of Anticoagulation Discontinuation in Atrial Fibrillation After PVI

Dangers of Anticoagulation Discontinuation in Atrial Fibrillation After PVI

By

Patients with a CHA2DS2-VASc score of 2 or more who discontinued warfarin had higher rates of stroke than those who continued treatment.

Sign Up for Free e-Newsletters